Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Jizhou Ai"'
Autor:
Farid Chekani, Zitong Zhu, Rezaul Karim Khandker, Jizhou Ai, Weilin Meng, Emma Holler, Paul Dexter, Malaz Boustani, Zina Ben Miled
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract Machine learning models can help improve health care services. However, they need to be practical to gain wide-adoption. In this study, we investigate the practical utility of different data modalities and cohort segmentation strategies when
Externí odkaz:
https://doaj.org/article/bc5f3c930e6c4f238371bfc9c3790ea7
Autor:
Emma Holler, Farid Chekani, Jizhou Ai, Weilin Meng, Rezaul Karim Khandker, Zina Ben Miled, Arthur Owora, Paul Dexter, Noll Campbell, Craig Solid, Malaz Boustani
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 9; Pages: 3286
This study aimed to develop and temporally validate an electronic medical record (EMR)-based insomnia prediction model. In this nested case-control study, we analyzed EMR data from 2011–2018 obtained from a statewide health information exchange. Th
Autor:
Jizhou Ai, Ricardo H. Alvarez, Damien Mikael Hansra, Maurie Markman, Eugene R Ahn, Anjanette Sorensen
Publikováno v:
Cancer Research. 80:P1-18
Background. Current standard of care for HR+HER2+ breast cancer >1cm per NCCN guidelines is chemotherapy with either trastuzumab(T) or trastuzumab and pertuzumab(TP) with anti-HER2 therapy continued for 1 year and anti-hormonal therapy for 5-10 years
Autor:
Jizhou Ai, Henri Brunengraber, Rafael A. Ibarra, Rajan S. Kombu, Kush Goyal, R. Abbas, Yana Sandlers, Juan Ramon Sanabria, Guo-Fang Zhang
Publikováno v:
HPB : The Official Journal of the International Hepato Pancreato Biliary Association
BackgroundThe incidence of liver disease is increasing in USA. Animal models had shown glutathione species in plasma reflects liver glutathione state and it could be a surrogate for the detection of hepatocellular carcinoma (HCC).MethodsThe present s
Autor:
Janine LoBello, Judit Moldvay, Glen J. Weiss, Balazs Hegedus, Balazs Dome, Jizhou Ai, Judit Papay, Jozsef Furak, Ildiko Szirtes, Ryan M. McCabe, Marton Gyulai, Katalin Fabian, Eszter Podmaniczky
Publikováno v:
Clinical Cancer Research. 20:B29-B29
Background: Neoadjuvant chemotherapy is used to help downstage cancer, and is widely used in locally-advanced breast cancer. Studies of Ki67 proliferation index in breast cancer have been fairly extensively evaluated. Comparison of core and surgical
Publikováno v:
20th International Conference on Advanced Information Networking & Applications - Volume 1 (AINA'06); 2006, p831-838, 8p
Autor:
Bradford A. Tan, George L. River, Eiko Kilmant, Kim Kramer, Donald P. Braun, Maurie Markman, Madappa N. Kundranda, Jizhou Ai
Publikováno v:
Journal of Clinical Oncology. 33:357-357
357 Background: Even with the advent of newer systemic therapies; long term survival in advanced PDAC is dismal. Hence there is an urgent need to use technologies such as NGS to identify potential therapeutic targets. Methods: A retrospective analysi
Publikováno v:
FUSION
In many useful video tracking situations, targets move through repeated mutual occlusions. As targets undergo occlusions, the feature subsets and combinations of those features that are effective in identifying the target and improving tracking perfo
Publikováno v:
SPIE Proceedings.
We address the problem of selecting features to improve automated video tracking of targets that undergo multiple mutual occlusions. As targets are occluded, different feature subsets and combinations of those features are effective in identifying th
Autor:
Bo Ding, Jizhou Ai, Alexander Statnikov, Nikita Igorevych Lytkin, Alexander V. Alekseyenko, Leonid Padyukov, Constantin F. Aliferis
Publikováno v:
Biology Direct
Biology Direct, Vol 6, Iss 1, p 25 (2011)
Biology Direct, Vol 6, Iss 1, p 25 (2011)
Background GWAS owe their popularity to the expectation that they will make a major impact on diagnosis, prognosis and management of disease by uncovering genetics underlying clinical phenotypes. The dominant paradigm in GWAS data analysis so far con